XML 33 R7.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($)
$ in Thousands
Total
Restricted Stock
Common Stock [Member]
Common Stock [Member]
Restricted Stock
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Beginning balance (in shares) at Dec. 31, 2022     33,477,000        
Beginning balance at Dec. 31, 2022 $ 211,605   $ 9   $ 1,182,568 $ 5,598 $ (976,570)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of common stock options (in shares)     10,000        
Exercise of common stock options 54       54    
Stock-based compensation 43,466       43,466    
Issuance of common stock (in shares)       2,930,000      
Issuance of common stock pursuant to the 2018 ESPP (in shares)     556,000        
Issuance of common stock pursuant to the 2018 ESPP 2,335       2,335    
Other comprehensive income (loss) (3,131)         (3,131)  
Net Income (Loss) (134,702)           (134,702)
Ending balance (in shares) at Dec. 31, 2023     39,728,000        
Ending balance at Dec. 31, 2023 134,798   $ 9   1,243,594 2,467 (1,111,272)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of common stock options (in shares)     6,000        
Exercise of common stock options 15       15    
Stock-based compensation 45,370       45,370    
Issuance of common stock (in shares)     3,592,000 3,503,000      
Issuance of common stock 27,451 $ 1   $ 1 27,451    
Issuance of common stock, net of issuance costs - ATM Offering Program (in shares)     3,908,000        
Issuance of common stock, net of issuance costs - ATM Offering Program 48,151       48,151    
Issuance of common stock pursuant to the 2018 ESPP (in shares)     520,000        
Issuance of common stock pursuant to the 2018 ESPP 2,262       2,262    
Termination of capped calls related to 2020 Convertible Senior Notes 115       115    
Other comprehensive income (loss) 1,134         1,134  
Net Income (Loss) (189,304)           (189,304)
Ending balance (in shares) at Dec. 31, 2024     51,257,000        
Ending balance at Dec. 31, 2024 69,993   $ 10   1,366,958 3,601 (1,300,576)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 31,945       31,945    
Issuance of common stock (in shares)     2,755,000 2,833,000      
Issuance of common stock $ 15,171 $ 0   $ 0 15,171    
Issuance of common stock pursuant to the 2018 ESPP (in shares) 610,588   424,000        
Issuance of common stock pursuant to the 2018 ESPP $ 639       639    
Other comprehensive income (loss) (5,597)         (5,597)  
Net Income (Loss) (103,488)           (103,488)
Ending balance (in shares) at Dec. 31, 2025     54,514,000        
Ending balance at Dec. 31, 2025 $ (6,508)   $ 10   $ 1,399,542 $ (1,996) $ (1,404,064)